Pritelivir is a selective antiviral helicase-primase complex inhibitor used in research settings to study the inhibition of herpes simplex virus replication. As a potent therapeutic candidate, accurate… Read more
Pritelivir is a selective antiviral helicase-primase complex inhibitor used in research settings to study the inhibition of herpes simplex virus replication. As a potent therapeutic candidate, accurate analytical testing of this compound requires high-quality reference standards, including the active pharmaceutical ingredient, potential process-related impurities, and related metabolites. Laboratories utilize these high-purity materials to perform rigorous impurity profiling, ensuring that any degradation products or synthesis byproducts are identified and quantified throughout the drug development lifecycle. Stable isotope labelled compounds for Pritelivir are particularly valuable for use as internal standards in mass spectrometry-based assays, such as LC-MS/MS, allowing for precise quantification and method validation. By incorporating these analytical tools, researchers can maintain strict quality control standards, ensuring the reliability and reproducibility of their data during the evaluation of this antiviral agent.